That indicated that COX-2 played a crucial role in the tumorigenesis, development and metastasis of pancreatic cancer, which suggests that COX-2 was one of the important targets of gene therapy in pancreatic cancer. This evidence concerns the gene PTGS2 and pancreatic neoplasm.